SEC 13F Intelligence

Decheng Capital Management III (Cayman), LLC / RCUS

Decheng Capital Management III (Cayman), LLC’s Arcus Biosciences Inc Position

Does Decheng Capital Management III (Cayman), LLC own Arcus Biosciences Inc (RCUS)? Yes — 869.8K shares worth $16M (+5.21% of its 13F portfolio) as of Q4 2023.

Position Value
$16M
Q4 2023
Shares
869.8K
% of Portfolio
+5.21%
Quarters Held
2
currently held

Position History RCUS

Reported value by quarter
Q3 ’23: $16MQ3 ’23Q4 ’23: $16MQ4 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2023869.8K$16M+5.21%
Q3 2023869.8K$16M+4.99%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Decheng Capital Management III (Cayman), LLC’s full portfolio or all institutional holders of RCUS.